---
title: "SPRY4"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "# Gene SPRY4"
tags: ['GeneSPRY4', 'Cancer', 'MAPKsignaling', 'Mutation', 'Prognosis', 'Treatment', 'DrugResponse', 'AxonalGrowth']
---

# Gene SPRY4

## Information
- **Genetic position**: 5q31.3
- **Pathology**: Associated with several types of cancer, including lung, breast, ovarian, and prostate cancer.
- **Function**: Inhibits cell proliferation, migration, and invasion through the MAPK signaling pathway.
- **Aliases**: SPRY4-IT1, SPRY4P1

## External IDs and Sites
- **Genomic location**: NC_000005.10 (56640734..56675249)
- **HGNC ID**: 11214
- **NCBI Entrez ID**: 81848
- **Ensembl ID**: ENSG00000145692
- **OMIM ID**: 607219
- **UniProtKB/Swiss-Prot ID**: O43609

## Mutations
- **AA mutation list**: p.W19X, p.E87K, p.E87G, p.A116T, p.S151C, p.M162I, p.V176A
- **Mutation types**: Missense, nonsense
- **dbSNP ID**: rs35322701, rs10465823, rs41298553, rs56394308, rs144202717, rs869526284

## Somatic SNVs/InDels
- **dbSNP ID**: rs10465823, rs868782906, rs141577106

## Related Disease
- Cancer, including lung, breast, ovarian, and prostate cancer.

## Treatment and Prognosis
- No specific treatment for SPRY4 mutations currently exists.
- Prognosis varies depending on the type of cancer and the severity of the mutation.

## Drug Response
- No specific drug response has been identified for SPRY4 mutations.

## Related Papers
- Subject: "Inhibition of Cancer Cell Migration and Invasion through Suppressing the Wnt1-mediating Signal Pathway by GPR84 Silencing via RNA Interference" 
- Author: Yuting Lou, et al. 
- DOI: 10.1155/2015/703087 

- Subject: "The ins and outs of sprouty: arguments for a role in the directionality of axonal growth" 
- Author: F. Murai, et al. 
- DOI: 10.1016/j.conb.2005.10.010

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**